Literature DB >> 25742454

Taming the inflammasome.

Maayan Levy1, Christoph A Thaiss1, Eran Elinav1.   

Abstract

Mesh：

Substances：

Year:  2015        PMID： 25742454     DOI： 10.1038/nm.3808

Source DB:  PubMed          Journal:  Nat Med        ISSN： 1078-8956            Impact factor:   53.440


× No keyword cloud information.
  13 in total

1.  Anti-inflammatory compounds parthenolide and Bay 11-7082 are direct inhibitors of the inflammasome.

Authors:  Christine Juliana; Teresa Fernandes-Alnemri; Jianghong Wu; Pinaki Datta; Leobaldo Solorzano; Je-Wook Yu; Rong Meng; Andrew A Quong; Eicke Latz; Charles P Scott; Emad S Alnemri
Journal:  J Biol Chem       Date:  2010-01-21       Impact factor: 5.157

2.  K⁺ efflux is the common trigger of NLRP3 inflammasome activation by bacterial toxins and particulate matter.

Authors:  Raúl Muñoz-Planillo; Peter Kuffa; Giovanny Martínez-Colón; Brenna L Smith; Thekkelnaycke M Rajendiran; Gabriel Núñez
Journal:  Immunity       Date:  2013-06-27       Impact factor: 31.745

Review 3.  Diet and host-microbial crosstalk in postnatal intestinal immune homeostasis.

Authors:  Nitya Jain; W Allan Walker
Journal:  Nat Rev Gastroenterol Hepatol       Date:  2014-09-09       Impact factor: 46.802

4.  Type I interferon inhibits interleukin-1 production and inflammasome activation.

Authors:  Greta Guarda; Marion Braun; Francesco Staehli; Aubry Tardivel; Chantal Mattmann; Irmgard Förster; Matthias Farlik; Thomas Decker; Renaud A Du Pasquier; Pedro Romero; Jürg Tschopp
Journal:  Immunity       Date:  2011-02-25       Impact factor: 31.745

5.  The microbial metabolite butyrate regulates intestinal macrophage function via histone deacetylase inhibition.

Authors:  Pamela V Chang; Liming Hao; Stefan Offermanns; Ruslan Medzhitov
Journal:  Proc Natl Acad Sci U S A       Date:  2014-01-03       Impact factor: 11.205

6.  Identification and characterization of a novel class of interleukin-1 post-translational processing inhibitors.

Authors:  D G Perregaux; P McNiff; R Laliberte; N Hawryluk; H Peurano; E Stam; J Eggler; R Griffiths; M A Dombroski; C A Gabel
Journal:  J Pharmacol Exp Ther       Date:  2001-10       Impact factor: 4.030

Review 7.  The immune system as a sensor of the metabolic state.

Authors:  Justin I Odegaard; Ajay Chawla
Journal:  Immunity       Date:  2013-04-18       Impact factor: 31.745

Review 8.  Ketone bodies as signaling metabolites.

Authors:  John C Newman; Eric Verdin
Journal:  Trends Endocrinol Metab       Date:  2013-10-18       Impact factor: 12.015

9.  The ketone metabolite β-hydroxybutyrate blocks NLRP3 inflammasome-mediated inflammatory disease.

Authors:  Yun-Hee Youm; Kim Y Nguyen; Ryan W Grant; Emily L Goldberg; Monica Bodogai; Dongin Kim; Dominic D'Agostino; Noah Planavsky; Christopher Lupfer; Thirumala D Kanneganti; Seokwon Kang; Tamas L Horvath; Tarek M Fahmy; Peter A Crawford; Arya Biragyn; Emad Alnemri; Vishwa Deep Dixit
Journal:  Nat Med       Date:  2015-02-16       Impact factor: 53.440

10.  A small-molecule inhibitor of the NLRP3 inflammasome for the treatment of inflammatory diseases.

Authors:  Rebecca C Coll; Avril A B Robertson; Jae Jin Chae; Sarah C Higgins; Raúl Muñoz-Planillo; Marco C Inserra; Irina Vetter; Lara S Dungan; Brian G Monks; Andrea Stutz; Daniel E Croker; Mark S Butler; Moritz Haneklaus; Caroline E Sutton; Gabriel Núñez; Eicke Latz; Daniel L Kastner; Kingston H G Mills; Seth L Masters; Kate Schroder; Matthew A Cooper; Luke A J O'Neill
Journal:  Nat Med       Date:  2015-02-16       Impact factor: 53.440
View more
  15 in total

Review 1.  Immune Cell Regulatory Pathways Unexplored as Host-Directed Therapeutic Targets for Mycobacterium tuberculosis: An Opportunity to Apply Precision Medicine Innovations to Infectious Diseases.

Authors:  Robert N Mahon; Richard Hafner
Journal:  Clin Infect Dis       Date:  2015-10-15       Impact factor: 9.079

Review 2.  The inflammasome as a target for pain therapy.

Authors:  H Zhang; F Li; W-W Li; C Stary; J D Clark; S Xu; X Xiong
Journal:  Br J Anaesth       Date:  2016-12       Impact factor: 9.166

3.  Inhibition of NLRP3 Inflammasome Ameliorates Cerebral Ischemia-Reperfusion Injury in Diabetic Mice.

Authors:  Pu Hong; Feng-Xian Li; Ruo-Nan Gu; Ying-Ying Fang; Lu-Ying Lai; Yong-Wei Wang; Tao Tao; Shi-Yuan Xu; Zhi-Jian You; Hong-Fei Zhang
Journal:  Neural Plast       Date:  2018-04-24       Impact factor: 3.599

4.  α1-antitrypsin mitigates NLRP3-inflammasome activation in amyloid β1-42-stimulated murine astrocytes.

Authors:  Taraneh Ebrahimi; Marcus Rust; Sarah Nele Kaiser; Alexander Slowik; Cordian Beyer; Andreas Rembert Koczulla; Jörg B Schulz; Pardes Habib; Jan Philipp Bach
Journal:  J Neuroinflammation       Date:  2018-09-27       Impact factor: 8.322

5.  Functional Role of Inflammasome Activation in a Subset of Obese Nonsmoking Patients with Severe Asthma.

Authors:  Paolo Ruggeri; Gaetano Caramori
Journal:  Am J Respir Crit Care Med       Date:  2019-05-01       Impact factor: 21.405

6.  Neurexin 3 transmembrane and soluble isoform expression and splicing haplotype are associated with neuron inflammasome and Alzheimer's disease.

Authors:  Akitoyo Hishimoto; Olga Pletnikova; Doyle Lu Lang; Juan C Troncoso; Josephine M Egan; Qing-Rong Liu
Journal:  Alzheimers Res Ther       Date:  2019-03-21       Impact factor: 6.982

Review 7.  Therapeutic Potential of Exogenous Ketone Supplement Induced Ketosis in the Treatment of Psychiatric Disorders: Review of Current Literature.

Authors:  Zsolt Kovács; Dominic P D'Agostino; David Diamond; Mark S Kindy; Christopher Rogers; Csilla Ari
Journal:  Front Psychiatry       Date:  2019-05-23       Impact factor: 4.157

Review 8.  Beneficial Effects of Exogenous Ketogenic Supplements on Aging Processes and Age-Related Neurodegenerative Diseases.

Authors:  Zsolt Kovács; Brigitta Brunner; Csilla Ari
Journal:  Nutrients       Date:  2021-06-26       Impact factor: 5.717

Review 9.  Immunomodulatory Effects of Diterpenes and Their Derivatives Through NLRP3 Inflammasome Pathway: A Review.

Authors:  Muhammad Torequl Islam; Sanaa K Bardaweel; Mohammad S Mubarak; Wojciech Koch; Katarzyna Gaweł-Beben; Beata Antosiewicz; Javad Sharifi-Rad
Journal:  Front Immunol       Date:  2020-09-25       Impact factor: 7.561

Review 10.  Ketogenic Diet as a Preventive and Supportive Care for COVID-19 Patients.

Authors:  Elena Gangitano; Rossella Tozzi; Orietta Gandini; Mikiko Watanabe; Sabrina Basciani; Stefania Mariani; Andrea Lenzi; Lucio Gnessi; Carla Lubrano
Journal:  Nutrients       Date:  2021-03-20       Impact factor: 5.717
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.